Zydus Lifesciences (ZYDUSLIFE) — Board Meeting

Zydus Lifesciences Limited's board approved a special resolution on November 6, 2025, seeking shareholder approval to raise ₹5,000 Crores through equity shares, convertible securities, and debentures via QIP, rights issue, or private placement. Funds will support debt repayment, organic/inorganic growth, and capex. Remote e-voting runs November 13–December 12, 2025. The Board has broad discretion on pricing (SEBI floor with up to 5% discount), allocation terms, and issuance structure, subject to regulatory approvals. Allotment must complete within 365 days.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this board meeting affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 11 November 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 11 November 2025

TATAPOWER Tata Power Company Limited Financial Results SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results SHRIRAMFIN Shriram Finance Limited Corporate Action TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.